These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 36134621)
1. Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface Glycans. Parafioriti M; Ni M; Petitou M; Mycroft-West CJ; Rudd TR; Gandhi NS; Ferro V; Turnbull JE; Lima MA; Skidmore MA; Fernig DG; Yates EA; Bisio A; Guerrini M; Elli S Chemistry; 2023 Jan; 29(1):e202202599. PubMed ID: 36134621 [TBL] [Abstract][Full Text] [Related]
2. The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming. Paiardi G; Ferraz M; Rusnati M; Wade RC Proc Natl Acad Sci U S A; 2024 Oct; 121(43):e2404892121. PubMed ID: 39401361 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening. Li B; Zhang T; Cao H; Ferro V; Li J; Yu M Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003304 [TBL] [Abstract][Full Text] [Related]
4. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
5. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
7. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169 [TBL] [Abstract][Full Text] [Related]
8. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin. Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089 [TBL] [Abstract][Full Text] [Related]
9. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction. Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086 [TBL] [Abstract][Full Text] [Related]
10. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states. Peters MH; Bastidas O; Kokron DS; Henze CE PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884 [TBL] [Abstract][Full Text] [Related]
11. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655 [TBL] [Abstract][Full Text] [Related]
13. Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II. Wang X; Bie L; Gao J J Chem Inf Model; 2022 Feb; 62(3):656-667. PubMed ID: 35060381 [TBL] [Abstract][Full Text] [Related]
16. How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics? Abduljalil JM; Elghareib AM; Samir A; Ezat AA; Elfiky AA Int J Biol Macromol; 2023 Jul; 242(Pt 4):125153. PubMed ID: 37268078 [TBL] [Abstract][Full Text] [Related]
17. The structural basis of accelerated host cell entry by SARS-CoV-2†. Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497 [TBL] [Abstract][Full Text] [Related]
18. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation. Rui L; Haonan L; Wanyi C Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk. Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769 [TBL] [Abstract][Full Text] [Related]
20. Structural basis of severe acute respiratory syndrome coronavirus 2 infection. Ge J; Zhang S; Zhang L; Wang X Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]